Leading Growth Driver in the Closed System Transfer Devices Market in 2025: Rising Cancer Incidence Fueling Growth in the Closed System Transfer Devices Market Driver's Influence

What market dynamics are playing a key role in accelerating the growth of the closed system transfer devices market?
The closed-system transfer devices market is anticipated to surge due to the rising prevalence of cancer. This health condition, noted by the unregulated growth and division of atypical cells, can infiltrate neighboring tissues and metastasize to other parts of the body via the blood and lymphatic systems. Various contributors to the escalated incidences of cancer include lifestyle habits, environmental factors, and heightened infection rates. Closed-system transfer devices play a key role in treating cancer, shielding healthcare professionals and patients from the hazards of manipulating and dispensing chemotherapy drugs. Utilizing these devices encourages a safer healthcare sphere and improved cancer treatment outcomes. For example, in February 2024, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, projected that cancer cases would skyrocket to over 35 million by 2050, indicating a 77% surge from the expected 20 million cases for 2022. This considerable increase underlines the escalating global impact of cancer. Moreover, the US-based National Center for Biotechnology Information forecasted in January 2023, that there would be 1,958,310 new cancer diagnoses in the United States and an estimated 609,820 cancer-related deaths in 2023. Consequently, the growth in cancer cases fuels the expansion of the closed system transfer devices market.

Get Your Closed System Transfer Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

How will the growth rate of the closed system transfer devices market shape industry trends by 2034?
In recent years, the market for closed system transfer devices has experienced rapid expansion. Its value is set to rise from $1.04 billion in 2024 to $1.19 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. The growth observed in the historic period has been driven by a surge in oncology drug approvals, enhanced focus on occupational safety, a heightened need to reduce needlestick injuries and exposure to hazardous drugs, increased cognizance of the risks associated with cytotoxic drug exposure, and a rising patient population undergoing chemotherapy.

In the coming years, the closed system transfer devices market is anticipated to undergo significant expansion. By 2029, the market is projected to reach $2.03 billion, registering a compound annual growth rate (CAGR) of 14.3%. This projected surge during the forecast period can be linked to factors such as an upsurge in cancer cases, heightened need for compliance monitoring to safely manage harmful drugs, growing consciousness about the use of closed system transfer devices, and increased adoption of CSTDS for conveying risky medications. The proliferation of drug approvals for cancer also contributes to this growth. Key trends expected to emerge during the forecast phase comprise the introduction of new products prioritizing safety, the evolution of digital platforms, and user-friendly devices. Extensive research and development initiatives, technological progress, and the embracing of membrane-to-membrane systems also comprise noteworthy trends.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

What trends are poised to drive the future success of the closed system transfer devices market?
Key players in the closed system transfer devices (CSTD) market are directing their efforts towards the creation of revolutionary syringe units to heighten safety standards, augment user engagement, minimize contamination possibility, and align with tight regulatory measures in the health sector. A full volume use syringe unit represents a syringe engineered to distribute or apply the total volume of a fluid or drug it holds, negating the requirement for additional combining or diluting processes. To illustrate, Equashield, an American medical device firm, unveiled the EQUASHIELD Syringe Unit in October 2023, which got FDA approval for full-volume usage, facilitating safer and more productive management of hazardous drugs. This ingenious design blocks the escape of vapour and contamination of the plunger, rendering it a budget-friendly option for blending and applying medicines.

Which primary segments of the closed system transfer devices market are driving growth and industry transformations?
The closed system transfer devices market covered in this report is segmented -

1) By Type: Needleless Systems, Membrane-To-Membrane Systems
2) By Technology: Diaphragm-Based, Compartmentalized, Filtration
3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems
4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:
1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters
2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the closed system transfer devices market landscape?
Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

What Is Covered In The Closed System Transfer Devices Global Market Report?

•Market Size Forecast: Examine the closed system transfer devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the closed system transfer devices market for a structured understanding.
•Key Players Overview: Analyze major players in the closed system transfer devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the closed system transfer devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the closed system transfer devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the closed system transfer devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the closed system transfer devices market.
•Competitive Landscape: Review strategic developments in the closed system transfer devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.